Copyright ©The Author(s) 2021.
World J Gastroenterol. Sep 21, 2021; 27(35): 5890-5907
Published online Sep 21, 2021. doi: 10.3748/wjg.v27.i35.5890
Figure 1
Figure 1 A suggested diagnostic algorithm is depicted. GERD: Gastroesophageal reflux disease; H. pylori: Helicobacter pylori; MEN-1: Multiple endocrine neoplasia type 1; PPIs: Proton pump inhibitors; ULN: Upper limit of normal; ZES: Zollinger Ellison syndrome.
Figure 2
Figure 2 A proposed therapeutic algorithm is represented based on both evidence from literature and personal own experience. 1Allocation driving prognostic factors are performance status, age, metastatic disease burden and pattern, comorbidities. CT: Computed tomography; dNEN: Duodenal neuroendocrine neoplasm; EUS: Endoscopic ultrasound; H2: Histamine receptor 2: LT: Orthotopic liver transplantation; MEN-1: Multiple endocrine neoplasia type 1; MRI: Magnetic resonance imaging; PET: Positron emission tomography; pNEN: Pancreatic NEN; PPIs: Proton pump inhibitors; PRRT: Peptide-radioreceptor therapy; SSAs: Somatostatin analogs; TACE: Transarterial chemoembolization; TARE: Transarterial radioembolization; ZES: Zollinger Ellison syndrome.